BILI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bilibili is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has meaningful analyst upside on paper, but the current price action is weak, proprietary signals are absent, and the technical trend is still bearish. For an impatient investor who does not want to wait for a better entry, this is still not the right entry point. My direct view: hold off for now.
BILI is trading at 17.2015, essentially at the S1 support zone of 17.225 and just above S2 at 16.198. The short-term setup is weak: MACD histogram is -0.26 and still below zero, showing bearish momentum; RSI_6 at 25.537 is oversold/weak but not a clean reversal signal; and moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, which confirms a downtrend. The stock is near support, but not showing a confirmed turn higher.
Macquarie, Morgan Stanley, Citi, BofA, and JPMorgan all lean bullish overall, with several upgrades and raised targets.
The stock price is weak right now, with the market closed at 17.2015 after a down session. Technicals remain bearish, and there is no AI Stock Picker or SwingMax signal today. Hedge fund and insider trading trends are both neutral, so there is no strong conviction buying from informed holders. No recent congress trading data or influential-person trading activity was reported.
No detailed latest-quarter financial statements were provided because the financial snapshot returned an error. From the news and analyst commentary, the latest quarter appears to have been strong, especially in advertising growth, with AI-related investment and R&D expected to rise but partly offset by cost management. The latest quarter season referenced in analyst commentary is Q1 2026.
Wall Street sentiment is bullish overall. Recent actions include JPMorgan upgrading to Overweight with a $35 target, Morgan Stanley upgrading to Overweight with a $31 target, Citi upgrading to Buy with a $27 target, BofA maintaining Buy with a $30 target, and Macquarie keeping Outperform while raising its target to $30. Pros: stronger ad growth, AI tailwinds, improved game pipeline visibility, and attractive valuation after the pullback. Cons: gaming faces a high base effect, AI investment may pressure profit near term, and the stock has already corrected significantly, which reflects lingering market caution.
